A carregar...
Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway
Metformin, as the first-line oral drug for type 2 diabetes, has proven benefits against aging, cancer and cardiovascular diseases. But the influence of metformin to the immune response and its molecular mechanisms remain obscure. Metformin increases resistance to not only the Gram-negative pathogens...
Na minha lista:
| Publicado no: | Virulence |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6961722/ https://ncbi.nlm.nih.gov/pubmed/31851866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21505594.2019.1706305 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|